Trials / Conditions / Neuroendocrine Tumor G2
Neuroendocrine Tumor G2
3 registered clinical trials studyying Neuroendocrine Tumor G2.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors NCT03375320 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors NCT01841736 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or L NCT00569127 | National Cancer Institute (NCI) | Phase 3 |